CRBP
NASDAQ · Biotechnology
Corbus Pharmaceuticals Holdi
$9.25
+0.18 (+1.98%)
Open$9.14
Previous Close$9.07
Day High$9.49
Day Low$9.08
52W High$20.56
52W Low$7.12
Volume—
Avg Volume588.9K
Market Cap171.38M
P/E Ratio—
EPS$-5.81
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+31.4% upside
Current
$9.25
$9.25
Target
$12.15
$12.15
$8.71
$12.15 avg
$17.60
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 72.40M | 73.75M | 70.02M |
| Net Income | -2,537,554 | -2,715,843 | -3,439,667 |
| Profit Margin | -3.5% | -3.7% | -4.9% |
| EBITDA | -3,891,696 | -4,515,140 | -4,413,459 |
| Free Cash Flow | -4,239,895 | -2,837,667 | -3,192,005 |
| Rev Growth | +4.2% | -7.8% | -7.0% |
| Debt/Equity | 0.37 | 0.31 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $261.07 | +3.99% | 126.9 | 461.26B |
| AMGN | Amgen Inc | $374.15 | +3.55% | 25.9 | 201.93B |
| GILD | Gilead Sciences Inc | $131.27 | +4.21% | 17.7 | 162.98B |
| VRTX | Vertex Pharmaceuticals Inc | $528.04 | +6.03% | 30.4 | 131.79B |
| REGN | Regeneron Pharmaceuticals | $654.27 | +4.73% | 15.5 | 68.59B |
| ALNY | Alnylam Pharmaceuticals Inc | $312.78 | +3.68% | 72.4 | 41.76B |